Analysts Unveil Top Picks: Lenskart, Groww, Max Healthcare Shine as Brokerages Issue Bold Ratings!

Analyst Wave: Brokerages Launch Coverage on Groww, Firstsource, Lenskart, Voltas, and Max Healthcare

A significant wave of analyst coverage has hit the Indian stock market as several leading brokerage firms initiate their research on prominent companies across diverse sectors. Jefferies, IIFL Finance, Macquarie, CLSA, and Goldman Sachs have unveiled fresh ratings and target prices, offering investors new insights and potential opportunities in fintech, business process outsourcing, eyewear retail, consumer durables, and healthcare.

Groww: Jefferies Sees Strong Earnings Trajectory

Jefferies has commenced its coverage of Groww, a leading digital investment platform, with a strong 'buy' recommendation and a target price set at ₹180. Analysts highlight Groww's impressive position as India's largest broker by active clients, despite its relatively recent inception in FY21. The firm anticipates a compelling 35% compounded annual growth rate (CAGR) in earnings per share (EPS) between FY26 and FY28.

This robust growth is expected to be fueled by several key drivers. The broking business is projected to expand by 19%, attributed to client retention and market share gains. Furthermore, new initiatives such as the margin trading facility and wealth management services are expected to experience a fivefold increase. Analyst projections also indicate a significant margin expansion of 700 basis points, underscoring a positive outlook for Groww's profitability.

Firstsource Solutions: IIFL Finance Bullish on BPO Leadership

IIFL Finance has initiated coverage on Firstsource Solutions, a prominent business process outsourcing (BPO) services provider, with a 'buy' recommendation and a target price of ₹420. The firm acknowledges Firstsource Solutions as the largest and most diversified pure-play BPO provider in India, boasting an annualised revenue exceeding $1 billion.

Analysts are particularly impressed by the company's "UnBPO" strategy, which represents a paradigm shift in the industry from a focus on scale and labor arbitrage to technology-driven solutions. Key aspects of this strategy include an "inch-wide, mile-deep" approach, domain-specific technology integration, and an outcome-oriented business model where over 50% of revenues are tied to performance-based pricing. The company's turnaround over the past two years, led by its new CEO under the "One Firstsource Strategy," has been credible, evidenced by an increase in large deal wins and strong new client acquisitions.

Lenskart: Macquarie Outperforms on Eyewear Giant

Macquarie has initiated coverage on Lenskart, India's leading eyewear retailer, with an 'outperform' rating and a target price of ₹530. The brokerage firm points to Lenskart's integrated supply chain as a significant competitive advantage, enabling efficiencies in cost, design, and overall operations. The company has a demonstrated track record of industry-leading growth.

Macquarie forecasts substantial market share gains for Lenskart, potentially expanding from its current 5% to over 40%, mirroring trends seen in other global markets. Improved supply chain utilisation is expected to boost earnings before interest, taxes, depreciation, and amortisation (EBITDA) margins towards 33%, alongside a tripling of the return on invested capital (ROIC) to over 20% by FY26-FY28.

Voltas: CLSA Holds Amidst Demand and Inventory Factors

CLSA has assigned a 'hold' rating to Voltas, a major player in air conditioning and engineering solutions, with a target price of ₹1,170. The company's management indicated a sequential improvement in room air conditioner (RAC) demand during Q3FY26, though overall annual demand might still see a decline. Inventory levels, while down from the previous quarter, remain elevated at 40–45 days, a significant increase compared to last year's 20–25 days.

Analysts noted instances of pre-buying activity driven by upcoming changes in energy efficiency standards. Voltas's pricing strategy is currently under evaluation, with several factors being considered for potential pass-through to end consumers. The firm views demand recovery in the RAC segment and clarity on pricing adjustments as key near-term triggers for the stock.

Max Healthcare: Goldman Sachs Initiates with Buy on Expansion

Goldman Sachs has initiated coverage on Max Healthcare Institute Limited with a 'buy' rating and a target price of ₹1,325. This initiation follows Max Healthcare's recent announcement of its entry into the Pune market through the acquisition of Yerawada Properties Private Limited (YPPL). The acquisition is structured as a step-up purchase.

Initially, the company intends to acquire 100% of the Class A equity shares, representing full voting rights and 50.22% of the economic interest in YPPL. Details regarding the remaining ownership stake have not yet been disclosed. Concurrently, Max Healthcare's board has approved the development of a new 450-bed super speciality hospital on land owned by YPPL, signalling a strategic expansion into a new geographical market.

Impact

These analyst initiations and recommendations carry significant weight for investors, offering a fresh perspective on the growth prospects and valuations of these companies. They can influence trading decisions, attract further investor interest, and set benchmarks for future performance. The diverse sectors covered highlight ongoing opportunities within the Indian economy, from digital services and outsourcing to consumer retail and healthcare infrastructure. Impact Rating: 7/10

Difficult Terms Explained

Broker: A firm or individual that arranges the buying and selling of securities (like stocks) for clients.
Active Clients: Customers who have made at least one transaction or logged into their trading account within a specific period.
FY21, FY26, FY28: Fiscal Year 2021, 2026, and 2028, referring to accounting periods typically ending on March 31.
Compounded Annual Growth Rate (CAGR): The average annual growth rate of an investment over a specified period longer than one year, assuming profits are reinvested.
Earnings Per Share (EPS): A company's net profit divided by the number of outstanding shares. It indicates how much profit is earned per share.
Margin Trading Facility: A service that allows investors to trade with borrowed funds from the broker, increasing potential gains but also risks.
Wealth Management: A comprehensive financial service that combines financial planning, investment portfolio management, and other financial services for individuals and families.
Basis Points (bps): A unit of measure used in finance to describe small percentage changes. One basis point is equal to 0.01% (1/100th of a percent).
BPO (Business Process Outsourcing): The practice of contracting with an external company to perform business-related operations, such as customer service or data entry.
Annualised Revenue: The total revenue of a company projected over a full year, often calculated by annualizing a portion of revenue (e.g., quarterly).
UnBPO: A term suggesting a modern, technology-driven, and outcome-focused approach to Business Process Outsourcing, distinct from traditional models.
Tech-arbitrage: Leveraging technological differences or advancements to gain a competitive advantage or cost savings.
Domain-contextualised Technology: Applying technology solutions that are specifically tailored and relevant to the particular industry or business domain.
Outcome-oriented Approach: A business strategy focused on achieving specific results or deliverables, often tied to performance metrics.
Outcome-based pricing: A pricing model where fees are directly linked to the achievement of specific business outcomes or performance targets.
Agile Business Model: A flexible and adaptable business structure designed to respond quickly to market changes and opportunities.
FY24: Fiscal Year 2024.
FY26: Fiscal Year 2026.
Annual Contract Value (ACV): The average revenue generated from a single customer contract.
Outperform Rating: An analyst rating suggesting a stock is expected to perform better than the average stock in its sector or the broader market.
Eyewear Retailer: A company that sells eyeglasses, sunglasses, and related accessories.
Integrated Supply Chain: A system where all stages of production, from raw materials to final delivery, are managed and coordinated cohesively.
Peers: Other companies operating in the same industry or sector.
EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation): A measure of a company's operating performance, excluding interest, taxes, depreciation, and amortisation expenses.
Return on Invested Capital (ROIC): A profitability ratio that measures how efficiently a company uses its capital to generate profits.
Sequentially: In comparison to the immediately preceding period (e.g., quarter-over-quarter).
Annualised Basis: Relating to a full year, often calculated by extrapolating data from a shorter period.
Inventory: Goods or materials that a business holds for sale or use in production.
Pre-buying: Purchasing a product in advance of its expected need or price increase.
Energy Efficiency (BEE table): Standards set by the Bureau of Energy Efficiency in India for appliances to ensure they consume less energy, often leading to product upgrades.
Pass through: The ability of a company to shift increased costs or new taxes onto its customers through higher prices.
Super speciality hospital: A hospital that provides highly specialised medical and surgical care.
Equity shares: Units of ownership in a corporation.
Economic interest: The financial benefit or claim a party has in an asset or business.